| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Contact lens-induced corneal fluorescein staining |
Using |
False |
Fluorescein stain (substance) |
Inferred relationship |
Some |
|
| Fluorescein-string test for upper GI bleeding |
Direct substance |
False |
Fluorescein stain (substance) |
Inferred relationship |
Some |
1 |
| fluoresceinnatrium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluorescein stain (substance) |
Inferred relationship |
Some |
|
| Opulets Fluorescein single-use eye drops 0.5mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluorescein stain (substance) |
Inferred relationship |
Some |
|
| fluoresceinnatrium-strip, 1 mg, til oftalmologisk anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluorescein stain (substance) |
Inferred relationship |
Some |
|
| fluoresceinnatrium 10 % øjendråber til engangsbrug |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluorescein stain (substance) |
Inferred relationship |
Some |
|
| fluoresceinnatrium 1 % øjendråber til engangsbrug |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluorescein stain (substance) |
Inferred relationship |
Some |
|
| Product containing fluorescein stain (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluorescein stain (substance) |
Inferred relationship |
Some |
1 |
| Opulets Fluorescein |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluorescein stain (substance) |
Inferred relationship |
Some |
|
| fluoresceinnatrium 200 mg/ml injektionsvæske, opløsning, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluorescein stain (substance) |
Inferred relationship |
Some |
|
| fluoresceinnatrium 0,6 mg strip |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluorescein stain (substance) |
Inferred relationship |
Some |
|
| Fluorescein sodium 10% injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluorescein stain (substance) |
Inferred relationship |
Some |
|
| Fluorescein sodium 25% injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluorescein stain (substance) |
Inferred relationship |
Some |
|
| proparacainhydrochlorid + fluoresceinnatrium 0,5 %/0,25 % øjendråber til engangsbrug |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluorescein stain (substance) |
Inferred relationship |
Some |
|
| lidokainhydrochlorid 4 % + fluoresceinnatrium 0,25 % øjendråber til engangsbrug |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluorescein stain (substance) |
Inferred relationship |
Some |
|
| Product containing fluorescein stain and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluorescein stain (substance) |
Inferred relationship |
Some |
2 |
| fluoresceinnatrium 10 % intraokulær injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluorescein stain (substance) |
Inferred relationship |
Some |
|
| fluoresceinnatrium 10 % intraokulær injektionsvæske, opløsning, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluorescein stain (substance) |
Inferred relationship |
Some |
|
| fluoresceinnatrium 25 % injektionsvæske, opløsning, hætteglas a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluorescein stain (substance) |
Inferred relationship |
Some |
|
| fluoresceinnatrium 25 % injektionsvæske, opløsning, hætteglas a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluorescein stain (substance) |
Inferred relationship |
Some |
|
| Fluorescein stain method (procedure) |
Direct substance |
False |
Fluorescein stain (substance) |
Inferred relationship |
Some |
|
| Fluorescein sodium stain (substance) |
Is a |
False |
Fluorescein stain (substance) |
Inferred relationship |
Some |
|
| Angiography of anterior segment fluorescein |
Direct substance |
False |
Fluorescein stain (substance) |
Inferred relationship |
Some |
2 |
| Angiography of posterior segment of eye using fluorescein |
Direct substance |
False |
Fluorescein stain (substance) |
Inferred relationship |
Some |
1 |
| Angiography of eye using fluorescein (procedure) |
Direct substance |
False |
Fluorescein stain (substance) |
Inferred relationship |
Some |
1 |
| Fluorescein + proparacaine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluorescein stain (substance) |
Inferred relationship |
Some |
|
| Ophthalmoscopy with medical evaluation, extended, with fluorescein angiography (procedure) |
Direct substance |
False |
Fluorescein stain (substance) |
Inferred relationship |
Some |
1 |
| Fluorescein staining of eye (procedure) |
Direct substance |
False |
Fluorescein stain (substance) |
Inferred relationship |
Some |
|
| fluoresceinfarveforsvindingstest |
Direct substance |
False |
Fluorescein stain (substance) |
Inferred relationship |
Some |
1 |
| Measures the time for the fluorescein dye to appear inside the nose after having been dropped on the eye. |
Direct substance |
False |
Fluorescein stain (substance) |
Inferred relationship |
Some |
1 |
| Jones dye test I (procedure) |
Direct substance |
False |
Fluorescein stain (substance) |
Inferred relationship |
Some |
1 |
| Jones dye test II (procedure) |
Direct substance |
False |
Fluorescein stain (substance) |
Inferred relationship |
Some |
1 |
| Angiography of anterior segment fluorescein |
Using substance (attribute) |
False |
Fluorescein stain (substance) |
Inferred relationship |
Some |
2 |
| Angiography of posterior segment of eye using fluorescein |
Using substance (attribute) |
True |
Fluorescein stain (substance) |
Inferred relationship |
Some |
1 |
| proparacainhydrochlorid + fluoresceinnatrium 0,5 %/0,25 % øjendråber til engangsbrug |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluorescein stain (substance) |
Inferred relationship |
Some |
|
| Angiography of eye using fluorescein (procedure) |
Using substance (attribute) |
True |
Fluorescein stain (substance) |
Inferred relationship |
Some |
1 |
| Product containing fluorescein stain and proxymetacaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluorescein stain (substance) |
Inferred relationship |
Some |
2 |
| Ophthalmoscopy with medical evaluation, extended, with fluorescein angiography (procedure) |
Using substance (attribute) |
False |
Fluorescein stain (substance) |
Inferred relationship |
Some |
1 |
| Jones dye test II (procedure) |
Direct substance |
False |
Fluorescein stain (substance) |
Inferred relationship |
Some |
1 |
| Jones dye test I (procedure) |
Direct substance |
False |
Fluorescein stain (substance) |
Inferred relationship |
Some |
1 |
| Fluorescein-string test for upper GI bleeding |
Direct substance |
False |
Fluorescein stain (substance) |
Inferred relationship |
Some |
1 |
| Measures the time for the fluorescein dye to appear inside the nose after having been dropped on the eye. |
Direct substance |
False |
Fluorescein stain (substance) |
Inferred relationship |
Some |
1 |
| fluoresceinfarveforsvindingstest |
Direct substance |
False |
Fluorescein stain (substance) |
Inferred relationship |
Some |
1 |
| Fluorescein-string test for upper GI bleeding |
Using substance (attribute) |
False |
Fluorescein stain (substance) |
Inferred relationship |
Some |
1 |
| Fluorescein-string test for upper GI bleeding |
Using substance (attribute) |
True |
Fluorescein stain (substance) |
Inferred relationship |
Some |
1 |
| Fluorescein stain method (procedure) |
Using substance (attribute) |
True |
Fluorescein stain (substance) |
Inferred relationship |
Some |
1 |
| Fluorescein angioscopy of eye (procedure) |
Using substance (attribute) |
True |
Fluorescein stain (substance) |
Inferred relationship |
Some |
1 |
| Product containing fluorescein in ophthalmic dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluorescein stain (substance) |
Inferred relationship |
Some |
|
| benoxinathydrochlorid + fluoresceinnatrium 0,3 %/0,125 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluorescein stain (substance) |
Inferred relationship |
Some |
|
| benoxinathydrochlorid + fluoresceinnatrium 0,4 %/0,25 % opløsning til oftalmisk anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluorescein stain (substance) |
Inferred relationship |
Some |
|
| Fluorescein sodium stain (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Fluorescein stain (substance) |
Inferred relationship |
Some |
|
| Product containing fluorescein stain in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluorescein stain (substance) |
Inferred relationship |
Some |
1 |
| Product containing only fluorescein stain (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluorescein stain (substance) |
Inferred relationship |
Some |
1 |
| Fluorescein stain and lidocaine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluorescein stain (substance) |
Inferred relationship |
Some |
2 |
| Fluorescein stain and proxymetacaine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluorescein stain (substance) |
Inferred relationship |
Some |
2 |
| Product containing only fluorescein stain in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluorescein stain (substance) |
Inferred relationship |
Some |
1 |
| Fluorescein staining of eye (procedure) |
Using substance (attribute) |
True |
Fluorescein stain (substance) |
Inferred relationship |
Some |
1 |
| Fluorescein stain and oxybuprocaine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluorescein stain (substance) |
Inferred relationship |
Some |
2 |
| Product containing fluorescein stain and oxybuprocaine in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluorescein stain (substance) |
Inferred relationship |
Some |
2 |
| Product containing only fluorescein stain and oxybuprocaine in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluorescein stain (substance) |
Inferred relationship |
Some |
2 |
| Product containing only fluorescein stain and proxymetacaine in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluorescein stain (substance) |
Inferred relationship |
Some |
2 |
| Fluorescein stain- and proxymetacaine-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluorescein stain (substance) |
Inferred relationship |
Some |
2 |
| Product containing fluorescein stain and oxybuprocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluorescein stain (substance) |
Inferred relationship |
Some |
2 |
| Dye disappearance test (procedure) |
Using substance (attribute) |
True |
Fluorescein stain (substance) |
Inferred relationship |
Some |
1 |
| Angiography of anterior segment fluorescein |
Using substance (attribute) |
True |
Fluorescein stain (substance) |
Inferred relationship |
Some |
1 |
| Ophthalmoscopy with medical evaluation, extended, with fluorescein angiography (procedure) |
Using substance (attribute) |
True |
Fluorescein stain (substance) |
Inferred relationship |
Some |
2 |
| Oral fluorescence imaging |
Using substance (attribute) |
True |
Fluorescein stain (substance) |
Inferred relationship |
Some |
1 |
| Fluorescence imaging of eye (procedure) |
Using substance (attribute) |
True |
Fluorescein stain (substance) |
Inferred relationship |
Some |
1 |
| Fluorescence imaging |
Using substance (attribute) |
False |
Fluorescein stain (substance) |
Inferred relationship |
Some |
1 |
| Measures the time for the fluorescein dye to appear inside the nose after having been dropped on the eye. |
Using substance (attribute) |
True |
Fluorescein stain (substance) |
Inferred relationship |
Some |
2 |
| Jones dye test I (procedure) |
Using substance (attribute) |
True |
Fluorescein stain (substance) |
Inferred relationship |
Some |
2 |
| Jones dye test II (procedure) |
Using substance (attribute) |
True |
Fluorescein stain (substance) |
Inferred relationship |
Some |
2 |
FHIR